胆固醇控制药物Vytorin（辛伐他汀，并替米贝）和Zetia（替米贝），被认为是他汀类药物(Statin)的重要替代品。不但能减少胆固醇，同时也能减少发生心脏病的危险。
基于12个网页-相关网页
Castline博士报告的试验结果显示，患者联用伊替米贝和辛伐他汀时颈内动脉粥样硬化的进展速度没有改善。
Castline presented the results which showed that there was no improvement in the rate of progression of carotid atherosclerosis and the patients that got ezetimibe added on to simvastatin.
两家公司称，ezetimibe(依替米贝，是Zetia的通用名)在动物实验中没有表现出致癌的危险，发现致癌的那个结论可能是偶然的。
The companies say that ezetimibe, the generic name for Zetia, showed no cancer risk in animal trials and argue that the cancer finding is probably a result of chance.
应用推荐